OSTEOARTHRITIS
Minimal benefit of annually repeated PRP injection in knee OA vs. non-recurring treatment
This report has been verified
by one or more authors of the
original publication.
Knee Surg Sports Traumatol Arthrosc. 2015 Aug;23(8):2170-7.
93 patients with early-stage osteoarthritis (OA) of the knee were randomized to receive either a single cycle of platelet-rich plasma (PRP) treatment consisting of 3 injections, or to receive the same treatment plus an additional second cycle, repeated 1 year later. Patients were followed-up for a minimum of 2 years after initiation of treatment. The purpose of the study was to determine if annual repetition of the treatment resulted in pain reduction, improvement in quality of life or ability to participate in activities compared to a single course of injections. Results indicated a significant benefit to pain, activity level, and quality of life in the repeat injection group 18 months into treatment, although the differences were no longer significant at 24 months.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
